Noriaki Emoto

Title: Noriaki Emoto: Innovator in Metalloprotease Research

Introduction

Noriaki Emoto is a distinguished inventor based in Ashiya, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of metalloprotease proteins. His work focuses on the treatment and prevention of conformational diseases, showcasing his commitment to advancing medical science.

Latest Patents

Noriaki Emoto holds a patent for a "Membrane-bound metalloprotease and soluble secreted form thereof." This patent discloses metalloprotease proteins or their salts that are usable for the treatment or prophylaxis of conformational diseases. Additionally, it provides a screening kit for the selection of carcinostatics and anti-metastatic agents. The metalloprotease proteins have an amino acid sequence set forth under SEQ ID NO:1 or NO:2 in the Sequence Listing. These proteins exhibit a neutral optimal pH and are capable of hydrolyzing endothelin 1, atrial natriuretic peptide, and angiotensin I. They are inhibited by 1,10-phenanthroline, phosphoramidon, and thiorphan.

Career Highlights

Throughout his career, Noriaki Emoto has demonstrated a strong dedication to research and innovation. His work has not only contributed to scientific knowledge but also holds potential therapeutic applications. His patent reflects his expertise and innovative approach in the field of metalloprotease research.

Collaborations

Noriaki Emoto has collaborated with notable colleagues, including Kayoko Saiki and Masafumi Matsuo. These collaborations have likely enriched his research and contributed to the advancement of their shared scientific goals.

Conclusion

Noriaki Emoto is a prominent figure in the field of metalloprotease research, with a patent that highlights his innovative contributions. His work has the potential to impact the treatment of various diseases, showcasing the importance of continued research and collaboration in the scientific community.